Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report

This paper presents a rare case of an elderly patient treated with erlotinib for disseminated lung adenocarcinoma with poor performance status (Eastern Cooperative Oncology Group performance status [PS]3). This treatment led to a long duration of complete remission according to Response Evaluation C...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovic, Dragana, Stevic, Ruza, Velinovic, Marta, Kontic, Milica, Maric, Dragana, Spasic, Jelena, Radosavljevic, Davorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593392/
https://www.ncbi.nlm.nih.gov/pubmed/28919784
http://dx.doi.org/10.2147/OTT.S131756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593392/
https://www.ncbi.nlm.nih.gov/pubmed/28919784
http://dx.doi.org/10.2147/OTT.S131756

Ejemplares similares